Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 075318
Company: CHARTWELL RX
Company: CHARTWELL RX
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
TICLOPIDINE HYDROCHLORIDE | TICLOPIDINE HYDROCHLORIDE | 250MG | TABLET;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
08/20/1999 | ORIG-1 | Approval |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/75-318_Ticlopidine_prntlbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/1999/75318ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/75-318_Ticlopidine.cfm |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
08/20/1999 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/75-318_Ticlopidine_prntlbl.pdf |